METHOD FOR THERAPEUTIC CORRECTION OF ANAEMIA IN CATS WITH CHRONIC KIDNEY DISEASE AT STAGE 3 ACCORDING TO IRIS Russian patent published in 2024 - IPC A61D99/00 A61K33/26 A61K35/28 A61K31/721 A61K31/714 A61K38/08 A61P7/06 

FIELD: medicine; veterinary science.

SUBSTANCE: invention relates to veterinary medicine, namely to therapy of internal non-communicable diseases of animals, and can be used for correction of anaemia in cats with chronic kidney disease at 3 stages according to IRIS. Darbepoetin alfa is injected subcutaneously in the area of abdominal wall in dose of 1.5 mcg/kg once a week. As soon as the haematocrit value reaches 25%, Darbepoetin alfa is introduced in a maintenance dose of 1 mcg/kg once in 2 weeks. Additionally, cyanocobalamin is administered subcutaneously in dose of 500 mcg once every 7 days for 4 injections, folic acid in dose of 250 mcg/kg is administered orally once every 24 hours for 21 days, and iron dextran in dose of 50 mg is administered intramuscularly once every 3 weeks.

EFFECT: method makes it possible to increase life expectancy of cats with chronic kidney disease by 3 stages according to IRIS, increasing synthesis of erythrocytes, which in turn corrects anaemia.

1 cl, 1 tbl, 1 ex